25320-Trzepacz, Paula

Paula T. Trzepacz, MD

Adjunct Clinical Professor of Psychiatry

GH 4800
Indianapolis, IN
Pubmed Logo


Dr. Trzepacz is a medical executive with academic medicine and pharmaceutical industry experience (Ph 2-4 Neurosciences drug development at Lilly) trained in psychosomatic medicine, geriatric psychiatry and neuropsychiatry. Clinical, teaching and research focus on cognitive and neurodegenerative disorders (Alzheimer’s, other dementias, delirium, TBI, ADHD), including diagnostic tools, drug development and biomarkers. Skills include trial design, data interpretation, publications, registration planning & submissions, product life cycle planning, and launches. Developed the Delirium Rating Scale-Revised-98, used worldwide for diagnosis and severity measurements of delirium. Professorships, NIH-funded research, and member of four journal editorial boards. As President of the American Neuropsychiatric Association and Academy of Psychosomatic Medicine, she led strategic planning and infrastructure reorganization that resulted in improved member value and fiscal standing. President & CEO of conXiome LLC for biopharma/biotech consulting. Currently Chief Medical Adviser for Elto Pharma, a subsidiary of Amarantus Bioscience Holdings Inc focused on neurodegenerative indications such as Parkinson’s disease L-DOPA-induced dyskinesia.

Titles & Appointments

  • Adjunct Clinical Professor of Psychiatry
  • Education
    1978 MD Dartmouth College
    1974 BA Wellesley College

Looking for patient care?

To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.

Find a doctor